Hedgehog	O
signaling	O
in	O
the	O
murine	O
melanoma	B-Cancer
microenvironment	O
.	O

The	O
Hedgehog	O
intercellular	B-Immaterial_anatomical_entity
signaling	O
pathway	O
regulates	O
cell	B-Cell
proliferation	O
and	O
differentiation	O
.	O

This	O
pathway	O
has	O
been	O
implicated	O
to	O
play	O
a	O
role	O
in	O
the	O
pathogenesis	O
of	O
cancer	B-Cancer
and	O
in	O
embryonic	B-Multi-tissue_structure
blood	I-Multi-tissue_structure
vessel	I-Multi-tissue_structure
development	O
.	O

In	O
the	O
current	O
study	O
,	O
Hedgehog	O
signaling	O
in	O
tumor	B-Cancer
related	O
vasculature	B-Multi-tissue_structure
and	O
microenvironment	O
was	O
examined	O
using	O
human	B-Cell
umbilical	I-Cell
vein	I-Cell
endothelial	I-Cell
cells	I-Cell
and	O
B16F0	B-Cell
(	O
murine	O
melanoma	B-Cancer
)	O
tumors	B-Cancer
models	O
.	O

Use	O
of	O
exogenous	O
Sonic	O
hedgehog	O
(	O
Shh	O
)	O
peptide	O
significantly	O
increased	O
BrdU	O
incorporation	O
in	O
endothelial	B-Cell
cells	I-Cell
in	O
vitro	O
by	O
a	O
factor	O
of	O
2	O
(	O
P	O
less	O
than	O
0	O
.	O
001	O
)	O
.	O

The	O
Hedgehog	O
pathway	O
antagonist	O
cyclopamine	O
effectively	O
reduced	O
Shh	O
-	O
induced	O
proliferation	O
to	O
control	O
levels	O
.	O

To	O
study	O
Hedgehog	O
signaling	O
in	O
vivo	O
a	O
hind	B-Cancer
limb	I-Cancer
tumor	I-Cancer
model	O
with	O
the	O
B16F0	B-Cell
cell	I-Cell
line	I-Cell
was	O
used	O
.	O

Treatment	O
with	O
25	O
mg	O
/	O
kg	O
cyclopamine	O
significantly	O
attenuated	O
BrdU	O
incorporation	O
in	O
tumor	B-Cell
cells	I-Cell
threefold	O
(	O
P	O
less	O
than	O
0	O
.	O
001	O
)	O
,	O
in	O
tumor	B-Cancer
related	O
endothelial	B-Cell
cells	I-Cell
threefold	O
(	O
P	O
=	O
0	O
.	O
004	O
)	O
,	O
and	O
delayed	O
tumor	B-Cancer
growth	O
by	O
4	O
days	O
.	O

Immunohistochemistry	O
revealed	O
that	O
the	O
Hedgehog	O
receptor	O
Patched	O
was	O
localized	O
to	O
the	O
tumor	B-Tissue
stroma	I-Tissue
and	O
that	O
B16F0	B-Cell
cells	I-Cell
expressed	O
Shh	O
peptide	O
.	O

Furthermore	O
,	O
mouse	O
embryonic	B-Cell
fibroblasts	I-Cell
required	O
the	O
presence	O
of	O
B16F0	B-Cell
cells	I-Cell
to	O
express	O
Patched	O
in	O
a	O
co	O
-	O
culture	O
assay	O
system	O
.	O

These	O
studies	O
indicate	O
that	O
Shh	O
peptide	O
produced	O
by	O
melanoma	B-Cell
cells	I-Cell
induces	O
Patched	O
expression	O
in	O
fibroblasts	B-Cell
.	O

To	O
study	O
tumor	B-Cancer
related	O
angiogenesis	O
a	O
vascular	B-Multi-tissue_structure
window	O
model	O
was	O
used	O
to	O
monitor	O
tumor	B-Cancer
vascularity	O
.	O

Treatment	O
with	O
cyclopamine	O
significantly	O
attenuated	O
vascular	B-Multi-tissue_structure
formation	O
by	O
a	O
factor	O
of	O
2	O
.	O
5	O
(	O
P	O
less	O
than	O
0	O
.	O
001	O
)	O
and	O
altered	O
vascular	B-Multi-tissue_structure
morphology	O
.	O

Furthermore	O
,	O
cyclopamine	O
reduced	O
tumor	B-Multi-tissue_structure
blood	I-Multi-tissue_structure
vessel	I-Multi-tissue_structure
permeability	O
to	O
FITC	O
labeled	O
dextran	O
while	O
having	O
no	O
effect	O
on	O
normal	O
blood	B-Multi-tissue_structure
vessels	I-Multi-tissue_structure
.	O

These	O
studies	O
suggest	O
that	O
Hedgehog	O
signaling	O
regulates	O
melanoma	B-Cancer
related	O
vascular	B-Multi-tissue_structure
formation	O
and	O
function	O
.	O

